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Membrane fusion in eukaryotic cells mediates the biogenesis of 
organelles, vesicular traffic between them, and exo- and endocytosis of 
important signaling molecules, such as hormones and 
neurotransmitters. Distinct tasks in intracellular membrane fusion have 
been assigned to conserved protein systems. Whereas tether proteins 
mediate initial recognition and attachment of membranes, SNARE 
protein complexes are considered as the core fusion engine. They 
provide mechanical energy to distort membranes and drive them 
through a hemifusion intermediate towards the formation of a fusion 
pore1-3. This last step is highly energy-demanding4,5. We combined the in 
vivo and in vitro fusion of yeast vacuoles with molecular simulations to 
show that tether proteins are critical to overcome the final energy barrier 
to fusion pore formation. SNAREs alone drive vacuoles only into 
hemifusion. Tether proteins greatly increase the volume of SNARE 
complexes and deform the site of hemifusion, which lowers the energy 
barrier for pore opening and provides driving force. Thereby, tether 
proteins assume a critical mechanical role in the terminal stage of 
membrane fusion, which is likely to be conserved at multiple steps of 
vesicular traffic. SNAREs and tether proteins should hence be 
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considered as a single, non-dissociable device to drive fusion. The core 
fusion machinery may then be larger and more complex than hitherto 
thought. 
 
SNAREs dock apposed membranes through stepwise assembly into 4-helix 
bundles. They exert mechanical force through their transmembrane domains 
(TMDs)1,2. This induces fusion of the outer leaflets (hemifusion), followed by 
inner leaflet fusion and pore formation. Pore formation can be preceded by full 
zippering of the 4-helix bundle6. Most studies on SNARE-driven fusion 
focused on synaptic SNAREs, which use unique cofactors, such as 
synaptotagmin, to fuse highly curved neurotransmitter vesicles with exquisite 
speed and temporal control7. Most SNARE-dependent fusion reactions do not 
require comparably rapid and controlled fusion, the membranes to be fused 
are much less curved, and their SNARE density is lower. Fusion driven solely 
by SNAREs becomes much less effective with increasing vesicle diameter 
and decreasing SNARE density8,9. Then, multi-subunit tether complexes 
become important. Tether complexes facilitate membrane contact and 
associate with the SNARE-binding SM proteins10-12. They promote trans-
SNARE pairing, possibly by increasing the local concentration of SNAREs 
and by supporting their conformational rearrangement. We investigated 
whether tether complexes might enhance the fusogenic potential of SNARE 
complexes, by increasing the force that SNAREs transmit to the bilayers, or 
by lowering the energy barrier for fusion pore formation.  
 
HOPS is the tether complex for vacuole and lysosome fusion. Vacuoles from 
cells deleted for the Rab7-GTPase Ypt7 lack HOPS (Fig. S1a)13. This 
prevents fusion and pairing between the vacuolar SNAREs Vam3, Vti1, Vam7 
and Nyv114. Incubating these membranes with soluble, recombinant vacuolar 
Qc-SNARE Vam7 (rVam7) allows to stimulate trans-SNARE pairing. Then, the 
reaction is independent of endogenous Vam7, which must otherwise be 
liberated by Sec18/NSF-dependent disruption of cis-SNARE complexes15. 
Fusion can hence proceed without ATP, avoiding interference by the ATP-
driven chaperone NSF, which disassembles SNARE complexes unless HOPS 
protects them14. To assay trans-SNARE pairing, we separately prepared 
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vacuoles from ypt7D or wildtype strains expressing Nyv1-HA or Vam3-myc. 
We mixed them in fusion reactions with rVam7 and measured trans-SNARE 
pairing through co-immunoadsorption of Vam3-myc with Nyv1-HA. Adding 
rVam7 to ypt7D vacuoles induced similar trans-SNARE pairing as in wildtype 
vacuoles (Fig. 1a,b). We measured content mixing by transfer of a 45 kDa 
enzyme between the fusion partners (Fig. S2), and lipid mixing by 
fluorescence dequenching through dilution of rhodamine-
phosphatidylethanolamine3,16. The trans-SNARE complexes on ypt7D 
vacuoles failed to induce content mixing (Fig. 1c), whereas lipid mixing was 
similar to wildtype (Fig. 1d,e). Thus, HOPS-free ypt7D vacuoles reached a 
hemifused state but failed to form a fusion pore, or to open it wide enough to 
let the reporter pass. Lipid mixing was sensitive to antibodies targeting the Qa-
SNARE Vam3 or the R-SNARE Nyv1, confirming that the reaction was 
SNARE-dependent. The ypt7D trans-SNARE complexes are probably fully 
zippered, because this is prerequisite for lipid mixing17.  
 
To test the effect of HOPS on pore opening, we accumulated ypt7D vacuoles 
for 60 min in the hemifused state, added purified HOPS or subcomplexes 
thereof (Fig. S1b), and assayed content mixing after 15 min of further 
incubation. HOPS is a hexameric complex with a globular SNARE-binding 
domain, which contains the SNARE-binding SM-protein Vps33 and its 
interactor Vps16 (Fig. 1f)18. Vps33 (79 kDa) did not stimulate fusion (Fig. 1g), 
whereas the bigger Vps33-Vps16 subcomplex (159 kDa) rescued fusion to 
80% of an untreated wildtype control, which had been incubated under 
standard fusion conditions with ATP. A Vps11-Vps39 subcomplex (240 kDa), 
representing the opposite end of HOPS without a SNARE interaction site, had 
no effect (Fig. 1g). As the biggest structure, HOPS (663 kDa) rescued ypt7D 
fusion to wildtype level. The endosomal CORVET complex, which is of similar 
size as HOPS and shares Vps33 with it11, stimulated fusion as well as HOPS 
(Fig. S3). The specificity of these complexes is hence restricted to their Rab-
GTPase-dependent function in membrane tethering. HOPS had not enhanced 
trans-SNARE pairing beyond the level attained by the preincubation with 
rVam7 (Fig. 1a,b) and it did not induce fusion in the absence of Vam7, nor 
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upon pre-incubating the vacuoles with antibodies to Vam3 (Figs. 1g, S4). 
Thus, rescue was SNARE-dependent. These results suggest an additional 
role of HOPS in fusion pore opening, which is independent of its known role in 
facilitating SNARE pairing12,19. 
 
To test whether pore opening might be driven by increased SNARE complex 
volume, we accumulated hemifused ypt7D vacuoles and added CBP-Vps33, 
which does not stimulate pore opening. When we tripled the effective 
molecular mass of Vps33 by adding a monoclonal antibody (150 kDa) to its 
CBP-tag, content mixing increased 5-fold and reached >50% of the wildtype 
signal (Fig. 2a). Antibodies did not stimulate fusion when Vps33 had been 
omitted, nor when Vps33 was used with a non-cognate HA-antibody. CBP-
Vps33 alone decreased content mixing of wildtype vacuoles by 60% and this 
inhibition could be partially overcome by adding CBP-antibodies. This can be 
understood if CBP-Vps33 outcompetes endogenous HOPS for SNARE 
binding but by itself does not add sufficient mass to stimulate fusion.   
 
Next, we replaced HOPS by artificial SNARE-binding proteins, using solely 
polyclonal antibodies to SNAREs (Fig. 2b). When added from the beginning of 
a reaction, SNARE antibodies interfere with trans-SNARE pairing and block 
fusion. To circumvent this block, we first accumulated ypt7D vacuoles in 
hemifusion, with trans-SNARE complexes already formed. Now, anti-Nyv1 or 
anti-Vam3 became strong stimulators. They rescued content mixing to 50% 
when added individually and to 100% when added simultaneously. Wildtype 
vacuoles, which contain sufficient amounts of endogenous HOPS, were 
hardly stimulated by the antibodies. Thus, artificial SNARE ligands substitute 
for HOPS in fusion pore opening in vitro.  
 
Since bivalent antibodies to SNAREs might promote fusion by clustering 
SNARE complexes around a fusion site, we generated monovalent Fab 
fragments from them (Fig. S1c). These inhibited fusion and trans-SNARE 
pairing when added before docking (Fig. 2c,d), but they potently stimulated 
content mixing of hemifused vacuoles without affecting trans-SNARE pairing. 
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Individual use of Fabs to either Vam3 or Nyv1 stimulated fusion weakly, 
probably because Fabs are smaller (56 kDa) than IgGs (150 kDa) and their 
dimensions permit to place no more than two Fabs along a SNARE domain. 
Fabs to a single SNARE may therefore not add sufficient volume to SNARE 
complexes to drive pore opening. Crowding agents20, such as Ficoll 400, had 
no influence, suggesting that bulky SNARE complex ligands do not stimulate 
fusion by molecular crowding (Figs. S5,S3). Thus, HOPS may promote fusion 
pore formation in vitro by increasing the volume of SNARE complexes. 
 
We engineered an in vivo system for recruiting large ligands to SNAREs, 
using FKBP12 and FRB, two domains undergoing rapamycin-induced 
dimerization21. FKBP12 (12 kDa) was attached to the C-terminus of Vam7, 
which is close to the TMDs of the SNARE complex. FRB-GFP (38 kDa) was 
attached to Pfk1, a subunit of the octameric, soluble phosphofructokinase 
(850 kDa), which is unrelated to fusion (Figs. 3a,S1d,e). Rapamycin-
insensitive tor1-1 cells served as strain background to avoid side effects of 
rapamycin treatment through TOR signaling22. tor1-1 cells have multiple 
vacuoles under normal growth conditions. Rapamycin recruited Pfk1-FRB-
GFP to vacuoles within less than 10 min (Fig. 3b,c). These vacuoles fused, 
significantly reducing their number per cell. Recruitment, but not fusion, was 
observed, when FKBP12 was separated from Vam7 by a 35 amino acid linker 
(Fig. 3d,e). Vam7 lacking FKBP12 induced neither recruitment nor fusion (Fig. 
3b,c). Also an FRB-GFP chimera lacking phosphofructokinase did not 
provoke fusion (Fig. S6). 
 
In vivo, HOPS recruitment controls re-fusion of vacuoles following hypertonic 
shock23. Hypertonic shock fragments yeast vacuoles in <5min, Vps41 
becomes phosphorylated and dissociates into the cytosol, likely together with 
HOPS24. Vacuole recovery requires Vps41 dephosphorylation, reassociation 
of HOPS with vacuoles and fusion. Whereas re-fusion requires >60 min in 
wildtype cells, rapamycin-induced recruitment of Pfk1-FRB-GFP to SNAREs 
provoked premature fusion of these vacuolar fragments, circumventing the 
physiological inactivation of HOPS (Fig. S7). Fusion was not observed in cells 
lacking FKBP12 on Vam7, nor when rapamycin was omitted.  
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We explored the influence of bulky SNARE ligands by coarse-grained 
molecular dynamics (Fig. 4a). HOPS features a SNARE-binding domain of 
approximately 12-14 nm diameter, which probably encapsulates the SNARE 
complex11,18 (Fig. 1f). Binding a sphere of the size of this head region to 
SNAREs markedly affects the geometry of the hemifusion stalk (Fig. 4a). The 
stalk restrains the apposed membranes from separating, enforcing strong 
local curvature. We rationalized the acceleration of fusion from the apparent 
work (free energy) required to thin the hemifusion stalk (Fig. 4a,b and SI). 
Progression from hemifusion to pore opening decreases the mutual distance 
of the SNARE C-termini until they associate (Fig. 4a). The presence of a 
HOPS sphere (14 nm) halves the energetic cost of fusion pore opening (from 
67 kBT to 34 kBT) in a tension-less membrane system with 3 SNARE 
complexes (Figs. 4b, S8). Pore nucleation now requires far-less thinning of 
the stalk. We attribute the enhanced (non-leaky) fusion pore formation to (I) a 
partial, relative relaxation of the HOPS-induced curvature stress (~50 kBT; 
Figs. 4c,S9), and (II) a geometrical advantage because of the pre-existing 
curvature (Fig. S8). Smaller contributions can be made by an initial gain in 
SNARE pulling force (Fig. S10). Thus, HOPS stimulates pore opening by 
steric effects on the site of hemifusion.  
 
We can understand numerous unexplained findings from this perspective: (1) 
SNARE-associated tether protein complexes (Munc13 and its associated SM 
protein Munc18) are essential for fusion of synaptic vesicles. While this can 
reflect their role in SNARE complex assembly, Munc13/18 might also drive 
fusion itself25. Accordingly, mutations that reduce Munc18 affinity for SNAREs 
change fusion pore dynamics26. (2) Also mutating the yeast Munc18 homolog 
Sec1, which associates with the tether complex exocyst27, reduces exocytosis 
without reducing SNARE complex abundance28,29. (3) On vacuoles, mutations 
compromising Vps33 binding to vacuolar SNAREs impair content mixing more 
than lipid mixing and trans-SNARE pairing16 (4) HOPS also enhances 
liposome fusion more than trans-SNARE pairing30;  (5) binding to Sec17/a-
SNAP and Sec18/NSF renders trans-SNARE complexes more fusogenic17,31.  
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Our simulations and experimental observations suggest that SNARE-ligands 
can drive fusion irrespective of specific molecular properties, except for their 
size. Therefore, any ligand that substantially increases the volume of trans-
SNARE complexes close to their membrane anchors is expected to stimulate 
pore opening. Since SM proteins and tethering complexes are indispensable 
for fusion in multiple trafficking pathways11, we propose that the driving force 
that they can contribute to fusion is a critical and conserved feature of their 
function. In physiological membranes, SNAREs and the tether/SM protein 
system thus act as an integrated molecular machine, in which tether/SM 
proteins first facilitate SNARE pairing11 and then drive the very last step of 
fusion.  
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Figure 1: Effect of soluble Vam7 on lipid and content mixing. 
a, Trans-SNARE pairing. Vacuoles were isolated from wildtype (BJ3505) or isogenic ypt7D cells 
carrying Vam3-myc or Nyv1-HA. The two vacuole populations were mixed and incubated in 
fusion reactions with ATP, Vam7 and HOPS as indicated. After solubilisation, proteins were 
pulled down with anti-HA and analyzed by SDS-PAGE and Western blotting. b, Signals were 
quantified by infrared fluorescence scanning. Trans-SNARE pairing is indicated by co-adsorbed 
Vam3-myc and quantified through the ratio Vam3-myc/Nyv1-HA. Means ± s.d. are shown. n=3. 
c-e, Hemifusion in ypt7D vacuoles: Vacuoles from wildtype and ypt7D cells were incubated in 
ATP-free fusion reactions with 600 nM rVam7 and 10 mg/ml BSA. Antibodies (200 nM) had 
been added where indicated. c, Content mixing was determined after 60 min, using the 
activation of pro-alkaline phosphatase by a maturase from the fusion partners. d,e, Lipid mixing 
was followed by dequenching of the fluorescence of Rh-phosphatidylethanolamine, which had 
been integrated at self-quenching concentrations into one of the fusion partners. Means ± s.d. 
are shown. n=3. f, Structure of HOPS (from18). g, Effect of HOPS subcomplexes on content 
mixing. Vacuoles were incubated in fusion reactions as in C for 60 min, with anti-Vam3 where 
indicated. Then, the samples received 400 nM purified (CBP)-tagged HOPS sub-complexes or 
Vps33 and were incubated for further 15 minutes before content mixing was assayed. Means ± 
s.d. are shown. n=3. 
0 50 100 150 200
ypt7∆WT
∆
F/F
 (T
X-
10
0)
Time (min)
 WT
0
0,05
0,1
0,15
0,2
0,25
0,3
0,35
0,4
0 4 8 12 16 20 24 28 32
ATP+ ATP-
rVam7 rVam7 αSec18
rVam7 αNyv1 rVam7 αVam3
Time (min)
0
0,05
0,1
0,15
0,2
0,25
0,3
0,35
0,4
0 4 8 12 16 20 24 28 32
ATP+ ATP-
rVam7 rVam7 αSec18
rVam7 αNyv1 rVam7 αVam3
c ed
  
+
+
+
+
+
+
+
+
+
 
 
 
 
 
 
 
+
+
+
+
Fusion activity (%) 
HOPS
Vps33
Vps16/33
Vps11/39
HOPS
Vps33
Vps16/33
Vps11/39
Vacuoles 
+/- rVam7 or αVam3
+/- HOPS subunits
Measure 
content mixing
60 min 
15 min 
 
f
 ypt7∆
 Incubation I°
 Incubation II°
a
- Vam3-myc
- Nyv1-HA
55 -
35 -
kDa
ATP
rVam7
HOPS
+
+ +
+
+
+ +
+
- Vps41
70 - 
100 - 
WT ypt7∆
Va
m3
/N
yv
1 r
ati
o
ATP
rVam7
HOPS
+
+ +
+
+
+ +
+
0
1
2
3 WT ypt7∆b
Fig. 1 
αV
am
3
rVa
m7 I°
 II°
-
-
- +
AT
Pg
∆
F/F
 (T
X-
10
0)
0 50 100 150
ypt7∆
WT
Fusion activity %
αNyv1
αVam3
αSec18
rVa
m7
AT
P
+
+
+
+
+
 11 
 
Figure 2: Fusion pore opening driven by ligands increasing SNARE complex size in vitro. 
a, Vps33. Fusion reactions with wildtype and ypt7D vacuoles were started as in Fig. 1g. After 
the first 60 min incubation period, samples received recombinant CBP-Vps33 (400nM), 
antibodies to CBP or HA (200 nM), or buffer only. After further 15 min, content mixing was 
assayed. Means ± s.d. are shown. n=3. b, Antibodies. Two-stage fusion reactions were 
performed as in a, but only with rVam7. Antibodies (200 nM) against Vam3, Nyv1 or Sec18/NSF 
were added either during the first 60 min incubation (I°) or during the second incubation (II°) of 
15 min. Means ± s.d. are shown. n=3. c, Fab fragments. Experiment as in b, but with Fab 
fragments instead of antibodies. n=3. d, Trans-SNARE pairing was assayed using tagged 
strains as in Fig. 1a.  Reactions with staged addition of rVam7 and Fabs were run as in c. Means 
± s.d. are shown. n=3. 
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Figure 3: Effect of SNARE complex enlargement on vacuole fusion in vivo. 
a, Schematic view of rapamycin-induced FKBP12/FRB-tagged Pfk1-recruitment to the SNARE 
complex without and with a long linker between Vam7 and FKBP12. b, d, In vivo vacuole 
morphology. Logarithmically growing cells, carrying Pfk1-FRB-GFP and (b) Vam7 or Vam7-
2xFKBP12, or (d) Vam7-LL-2xFKBP12 with a 35 amino acid linker, were stained with the 
vacuole tracer FM4-64. Cells were incubated with 10 µM rapamycin for 10 min where indicated 
and analyzed by spinning disc microscopy. Scale bar: 5 µm. c, e, Quantification of b and d, 
respectively. The cells were grouped into three categories according to the number of vacuoles 
visible per cells. 100 cells were analyzed per sample. Means and s.d. are shown. n=3. 
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Figure 4: Molecular dynamics simulations on the influence of steric constraints at the 
(hemi-)fusion site.  
a, Simulation setup: Two hemifused membranes in the presence of the SNARE complex that is 
either free or bound to a sphere equivalent to the size of the SNARE-binding domain of HOPS 
(14 nm). The size of 'HOPS' and positioning of the SNARE complex are inspired by EM and 
crystal structures9,11,18. To enhance clarity, only one SNARE complex is illustrated. b, The free-
energy of fusion pore formation is derived by measuring the work (free energy) required to thin 
the stalk until fusion pore nucleation occurs32 (see Fig. S8). Arrows and dotted lines indicate the 
point of pore nucleation. c, Work distribution reflecting the equilibrium work that HOPS must 
perform to bend the membrane in the presence of a stalk (average work: 231+/- 4 kBT) or of a 
fusion pore (average work: 175 +/- 5 kBT), respectively. A reduction of ~50 kBT indicates that 
fusion pore formation is associated with release of local membrane stress. 
